622 related articles for article (PubMed ID: 17481896)
1. Synthesis and anticonvulsant activity of 4-(2-(2,6-dimethylphenylamino)-2-oxoethylamino)-N-(substituted)butanamides: a pharmacophoric hybrid approach.
Yogeeswari P; Sriram D; Sahitya P; Ragavendran JV; Ranganadh V
Bioorg Med Chem Lett; 2007 Jul; 17(13):3712-5. PubMed ID: 17481896
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of anticonvulsants from a combined phthalimide-GABA-anilide and hydrazone pharmacophore.
Ragavendran JV; Sriram D; Patel SK; Reddy IV; Bharathwajan N; Stables J; Yogeeswari P
Eur J Med Chem; 2007 Feb; 42(2):146-51. PubMed ID: 17011080
[TBL] [Abstract][Full Text] [Related]
3. Newer GABA derivatives for the treatment of epilepsy including febrile seizures: a bioisosteric approach.
Ragavendran JV; Sriram D; Kotapati S; Stables J; Yogeeswari P
Eur J Med Chem; 2008 Dec; 43(12):2650-5. PubMed ID: 18403060
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
He X; Zhong M; Zhang T; Wu W; Wu Z; Yang J; Xiao Y; Pan Y; Qiu G; Hu X
Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222
[TBL] [Abstract][Full Text] [Related]
5. 2,4-Dimethoxyphenylsemicarbazones with anticonvulsant activity against three animal models of seizures: synthesis and pharmacological evaluation.
Thirumurugan R; Sriram D; Saxena A; Stables J; Yogeeswari P
Bioorg Med Chem; 2006 May; 14(9):3106-12. PubMed ID: 16413192
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives.
Kamiński K; Rapacz A; Łuszczki JJ; Latacz G; Obniska J; Kieć-Kononowicz K; Filipek B
Bioorg Med Chem; 2015 May; 23(10):2548-61. PubMed ID: 25868743
[TBL] [Abstract][Full Text] [Related]
7. Design & synthesis of 2-(substituted aryloxy)-5-(substituted benzylidene)-3-phenyl-2,5-dihydro-1H-[1,2,4] triazin-6-one as potential anticonvulsant agents.
Kaushik D; Khan SA; Chawla G
Eur J Med Chem; 2010 Sep; 45(9):3960-9. PubMed ID: 20573424
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and anticonvulsant activity of N-phenylamino derivatives of 3,3-dialkyl-pyrrolidine-2,5-diones and hexahydro-isoindole-1,3-diones.
Kamiński K; Obniska J
Bioorg Med Chem; 2008 May; 16(9):4921-31. PubMed ID: 18375131
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticonvulsant activities of 4-N-substituted arylsemicarbazones.
Pandeya SN; Kohli S; Siddique N; Stables JP
Pol J Pharmacol; 2003; 55(4):565-71. PubMed ID: 14581715
[TBL] [Abstract][Full Text] [Related]
10. Preliminary evaluation of anticonvulsant activity and neurotoxicity of some 1,4-substituted piperazine derivatives.
Marona H; Gunia A; Słoczyńska K; Rapacz A; Filipek B; Cegła M; Opoka W
Acta Pol Pharm; 2009; 66(5):571-8. PubMed ID: 19894654
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, physicochemical and anticonvulsant properties of new N-[(4-arylpiperazin-1-yl)alkyl]-3-phenyl- and 3-(3-methyl-phenyl)-pyrrolidine-2,5-diones.
Obniska J; Chlebek I; Pichór J; Kopytko M; Kamiński K
Acta Pol Pharm; 2009; 66(6):639-47. PubMed ID: 20050528
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticonvulsant activity of some novel 3-aryl amino/amino-4-aryl-5-imino-Delta2-1,2,4-thiadiazoline.
Gupta A; Mishra P; Kashaw SK; Jatav V; Stables JP
Eur J Med Chem; 2008 Apr; 43(4):749-54. PubMed ID: 17624632
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel 2,5-disubstituted 1,3,4-thiadiazoles for their potential anticonvulsant activity: pharmacophoric model studies.
Rajak H; Deshmukh R; Aggarwal N; Kashaw S; Kharya MD; Mishra P
Arch Pharm (Weinheim); 2009 Aug; 342(8):453-61. PubMed ID: 19565600
[TBL] [Abstract][Full Text] [Related]
14. Benzothiazole incorporated barbituric acid derivatives: synthesis and anticonvulsant screening.
Siddiqui N; Ahsan W
Arch Pharm (Weinheim); 2009 Aug; 342(8):462-8. PubMed ID: 19565603
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of anticonvulsant activity of pyridinyl-pyrrolidones: a pharmacophore hybrid approach.
Siddiqui N; Ahsan W; Alam MS; Ali R; Srivastava K
Arch Pharm (Weinheim); 2012 Mar; 345(3):185-94. PubMed ID: 21997797
[TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant and neurotoxicity evaluation of some 6-substituted benzothiazolyl-2-thiosemicarbazones.
Yogeeswari P; Sriram D; Mehta S; Nigam D; Kumar MM; Murugesan S; Stables JP
Farmaco; 2005 Jan; 60(1):1-5. PubMed ID: 15652361
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Pharmacological Screening of Pyridazinone Hybrids as Anticonvulsant Agents.
Partap S; Yar MS; Hassan MZ; Akhtar MJ; Siddiqui AA
Arch Pharm (Weinheim); 2017 Oct; 350(10):. PubMed ID: 28863231
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins.
Zhu Q; Pan Y; Xu Z; Li R; Qiu G; Xu W; Ke X; Wu L; Hu X
Eur J Med Chem; 2009 Jan; 44(1):296-302. PubMed ID: 18396358
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of N4-(2,4-dimethylphenyl) semicarbazones as 4-aminobutyrate aminotransferase inhibitors.
Yogeeswari P; Sriram D; Thirumurugan R; Jeewanlal LR; Jit S; Ragavendran JV; Kavya R; Rakhra K; Saraswat V
Acta Pharm; 2006 Sep; 56(3):259-72. PubMed ID: 19831276
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of aryl semicarbazones as potential anticonvulsant agents.
Yogeeswari P; Sriram D; Veena V; Kavya R; Rakhra K; Ragavendran JV; Mehta S; Thirumurugan R; Stables JP
Biomed Pharmacother; 2005; 59(1-2):51-5. PubMed ID: 15740936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
